Today's News | Note: News feeds may no longer be available for the articles on this page.

China clears Johnson & Johnson baby products after probe 1:57 AM 3/21/2009
Reuters - USA
Chinese health authorities found no evidence of cancer-causing chemicals in baby products made by Johnson & Johnson. A US consumer group charged that they contained carcinogens. The fox may be watching the chicken coop. ...

Forest depression drug approved for adolescents 1:20 PM 3/20/2009
Forbes - NY,USA
Forest Laboratories said the US FDA approved its depression and anxiety drug Lexapro for use in children between the ages of 12 and 17 years old. ...

OSI Pharma files suit against Teva, Mylan 5:26 AM 3/20/2009
Reuters - USA
OSI Pharmaceuticals Inc filed two lawsuits against rival drug companies Teva Pharmaceutical Industries and Mylan Inc regarding patents associated with Tarceva (erlotinib) claiming patent infringement. ...

Warner Chilcott sues Impax over acne drug Doryx 12:12 PM 3/19/2009
The Associated Press
Warner Chilcott Ltd is suing Impax Laboratories Inc for possible infringement of its patent on 150 mg tablets of the acne medication Doryx (coated doxycycline hyclate pellets). ...

Drug Sales in US Rise at Slowest Rate in 47 Years 11:24 AM 3/19/2009
Bloomberg - USA
Retail sales of prescription drugs grew to over $290 billion, but the growth rate hasn't been this slow in nearly 50 years. ...

FDA panel backs Sanofi drug to treat heart rhythms 5:17 AM 3/19/2009
The Associated Press
Cardiology experts recommended that Multaq from Sanofi-Aventis be approved to treat irregular heart rhythms linked to stroke. ...

Scientists grow diabetes drug in tobacco plants 3:27 AM 3/19/2009
Reuters - USA
Scientists use genetically modified tobacco plants to stop type 1 diabetes. ...

Biosimilar bill offers 12 years of market exclusivity 7:17 PM 3/18/2009
FierceBiotech - Washington,DC,USA
Biotech lobbyists seem to like a newly-introduced bill that offers 12 years of market exclusivity to branded biologics. No details on the approval mechanism at FDA. ...

FDA denies Medicis petition to halt generic Solodyn 8:27 AM 3/18/2009
Reuters - USA
Medicis Pharmaceutical Corp's acne drug Solodyn (minocycline) will face generic competition sooner than expected. The US FDA denied a petition to stop generic versions. Teva Pharmaceutical Industries will launch a generic version of Solodyn with shipments already started. ...

Merck gives malaria drug to non-profit group 5:42 AM 3/18/2009
Reuters - USA
Merck & Co has donated an experimental anti-malarial drug to a not-for-profit research organization. It's one small step addressing health issues in poor countries. ...

FDA Clears Meda-Orexo Insomnia Drug For Marketing 5:08 PM 3/17/2009
FOXBusiness - USA
The US FDA cleared Meda AB to market Orexo's sublingual tablet formulation of Edluar (zolpidem) as a short-term treatment for insomnia. ...

Cephalon Rises on Bipolar-Drug Data 3:02 PM 3/17/2009
TheStreet.com - USA
Cephalon announced positive results from a phase II studies of Nuvigil in patients with bipolar depression. Cephalon will launch Nuvigil in the third quarter as a treatment for excessive sleepiness from sleep apnea, shift work sleep disorder, and other conditions. ...

Cedarburg Pharmaceuticals buys Denver firm ... 9:03 AM 3/17/2009
Bizjournals.com - Charlotte,NC,USA
Cedarburg Pharmaceuticals Inc has purchased Hauser Pharmaceutical Services. The new company Cedarburg Hauser Pharmaceuticals Inc will supply active ingredients. ...

FDA: Proposed Drug Rivaroxaban Has Bleeding Risk 9:01 AM 3/17/2009
CNNMoney.com - USA
Bayer AG's and Johnson & Johnson's Rivaroxaban faces a review by an FDA advisory panel Thursday. Rivaroxaban stops clots but caused increased bleeding in some patients. ...

Cytos vaccine fails mid-stage trial, shares slump 6:24 AM 3/17/2009
Reuters - USA
Cytos Biotechnology will cut about 40 percent of its workforce after a high blood pressure vaccine failed to meet its target in a mid-stage trial. ...

<- Day Earlier | Today's News